Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 296,683	$ 222,503
Short-term investments	86,644	57,812
Accounts receivable	123,330	78,286
Inventory	24,887	22,403
Prepaid expenses and other current assets	18,140	11,784
Total current assets	549,684	392,788
Restricted cash	1,482	425
Long-term investments	8,105	12,526
Property and equipment, net	1,862	1,139
Operating lease right-of-use assets	8,741	8,675
Intangible assets, net	260,921	249,819
Other assets	12,018	5,382
Total assets	842,813	670,754
Current liabilities:
Accounts payable	9,614	14,618
Accrued expenses and other current liabilities	196,185	111,933
Total current liabilities	205,799	126,551
Operating lease liabilities, noncurrent	7,516	7,972
Convertible notes payable, net, noncurrent	309,797	308,082
Other liabilities	5,011	2,509
Total liabilities	528,123	445,114
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of December 31, 2025 and 2024	0	0
Common stock, $0.0001 par value; 200,000,000 shares authorized; 51,896,391 and 48,338,096 shares issued and outstanding as of December 31, 2025 and 2024, respectively	5	5
Additional paid-in capital	981,878	870,189
Accumulated deficit	(667,544)	(644,181)
Accumulated other comprehensive income (loss)	351	(373)
Total stockholders’ equity	314,690	225,640
Total liabilities and stockholders’ equity	$ 842,813	$ 670,754